What’s new for ESC Congress 2013? (Amsterdam 30th August–4th September 2013) gan Keith A.A. Fox

Cael y testun llawn

What's new for ESC Congress 2013? (Amsterdam 30th August–4th September 2013) gan Keith A.A. Fox

Cael y testun llawn

Heart-Type Fatty Acid-Binding Protein in the Early Diagnosis of Acute Myocardial Infarction : The potential for influencing patient management gan Hafidh A Alhadi, Keith A A Fox

Cael y testun llawn

Validity of Cardiac Markers as Diagnostic and Prognostic Indicators of Complications in Patients undergoing Percutaneous Coronary Intervention gan Hafidh A Alhadi, Keith A A Fox

Cael y testun llawn

Clinical Characteristics and Outcomes of Patients with Peripheral Artery Disease in the Prospective XATOA Registry Study gan E. Sebastian Debus, Victor Aboyans, Sonia S. Anand, Keith A.A. Fox, Alain Gay, Kai Vogtländer, Uwe Zeymer

Cael y testun llawn

Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores. gan Krishna G Aragam, Umesh U Tamhane, Eva Kline-Rogers, Jin Li, Keith A A Fox, Shaun G Goodman, Kim A Eagle, Hitinder S Gurm

Cael y testun llawn

Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort. gan Marlous Hall, Tatendashe B Dondo, Andrew T Yan, Mamas A Mamas, Adam D Timmis, John E Deanfield, Tomas Jernberg, Harry Hemingway, Keith A A Fox, Chris P Gale

Cael y testun llawn

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER) gan Jan Beyer-Westendorf, A. John Camm, Keith A. A. Fox, Jean-Yves Le Heuzey, Sylvia Haas, Alexander G. G. Turpie, Saverio Virdone, Ajay K. Kakkar, for the RIVER Registry Investigators

Cael y testun llawn

Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome gan Liping Zhang, Xiaoyu Yan, Partha Nandy, Stefan Willmann, Keith A. A. Fox, Scott D. Berkowitz, Amarnath Sharma, Anne Hermanowski-Vosatka, Stephan Schmidt, Jeffrey I. Weitz, Dirk Garmann, Gary Peters

Cael y testun llawn

Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke gan Bernard J Gersh, Deborah M Siegal, Karen Pieper, Anne-Céline Martin, Keith A A Fox, Saverio Virdone, Shinya Goto, Alexander G G Turpie, Frederik H Verbrugge, John Camm, Pantep Angchaisuksiri

Cael y testun llawn

Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention gan Matthias Bossard, Christopher B. Granger, Jean‐Francois Tanguay, Gilles Montalescot, David P. Faxon, Sanjit S. Jolly, Petr Widimsky, Kari Niemela, Philippe Gabriel Steg, Madhu K. Natarajan, Peggy Gao, Keith A. A. Fox, Salim Yusuf, Shamir R. Mehta

Cael y testun llawn

Relationship of Platelet Reactivity With Bleeding Outcomes During Long‐Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non‐ST‐Segment Elevation Ac... gan Jan H. Cornel, E. Magnus Ohman, Benjamin Neely, Joseph A. Jakubowski, Deepak L. Bhatt, Harvey D. White, Diego Ardissino, Keith A.A. Fox, Dorairaj Prabhakaran, Paul W. Armstrong, David Erlinge, Udaya S. Tantry, Paul A. Gurbel, Matthew T. Roe

Cael y testun llawn

Frailty assessment and risk prediction by GRACE score in older patients with acute myocardial infarction gan Atul Anand, Sarah Cudmore, Shirley Robertson, Jacqueline Stephen, Kristin Haga, Christopher J. Weir, Scott A. Murray, Kirsty Boyd, Julian Gunn, Javaid Iqbal, Alasdair MacLullich, Susan D. Shenkin, Keith A. A. Fox, Nicholas Mills, Martin A. Denvir

Cael y testun llawn

Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry gan Ajay K Kakkar, Keith A A Fox, Sylvia Haas, Saverio Virdone, Jean-Pierre Bassand, Karen S Pieper, Alexander G G Turpie, Gloria Kayani, Seil Oh, Jörn Nielsen, Frank Cools, John Camm, Marianne Brodmann, Patricia Apenteng, Antonio C P Barretto

Cael y testun llawn

Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial gan Anthony P. Carnicelli, Anne S. Hellkamp, Kenneth W. Mahaffey, Daniel E. Singer, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Jonathan P. Piccini, Richard C. Becker, Christopher C. Nessel, Scott D. Berkowitz, Keith A. A. Fox, Robert M. Califf, Manesh R. Patel

Cael y testun llawn

Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial gan George C. Leef, Anne S. Hellkamp, Manesh R. Patel, Richard C. Becker, Scott D. Berkowitz, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Werner Hacke, Christopher C. Nessel, Daniel E. Singer, Keith A.A. Fox, Kenneth W. Mahaffey, Jonathan P. Piccini

Cael y testun llawn

Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AF gan Toon Wei Lim, Ralf E Harskamp, Karen Pieper, Freek Verheugt, Ajay K Kakkar, Keith A A Fox, Jelle C L Himmelreich, Sylvia Haas, Saverio Virdone, Shinya Goto, Ali Oto, Petr Jansky, John Camm, Harry Gibbs, Barry F Jacobson, J P S Sawhney

Cael y testun llawn

Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial gan Gene R. Quinn, Anne S. Hellkamp, Graeme J. Hankey, Richard C. Becker, Scott D. Berkowitz, Günter Breithardt, Maurizio Fava, Keith A. A. Fox, Jonathan L. Halperin, Kenneth W. Mahaffey, Christopher C. Nessel, Manesh R. Patel, Jonathan P. Piccini, Daniel E. Singer

Cael y testun llawn

Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF gan Leo Ungar, Fatima Rodriguez, Anne S. Hellkamp, Richard C. Becker, Scott D. Berkowitz, Guenter Breithardt, Keith A. A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Manesh R. Patel, Jonathan P. Piccini, Kenneth W. Mahaffey

Cael y testun llawn

Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis gan Josephine Harrington, Anne S. Hellkamp, Kenneth W. Mahaffey, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Richard C. Becker, Christopher C. Nessel, Scott D. Berkowitz, Keith A. A. Fox, Daniel E. Singer, Shaun G. Goodman, Manesh R. Patel, Jonathan P. Piccini

Cael y testun llawn